Biote Corp. Class A Common Stock
€1.738
EUR
Last updated on --.
24h volume220.48K
24h highest1.7388 EUR
24h lowest1.6355 EUR
24h Price movement+5.21%
BTMD recent prices
24 Hours
+5.21%+€0.08608
30 days
-11.38%-€0.22036
60 days
+53.38%+€0.5974
90 days
-5.94%-€0.10846
Key data
Previous close1.6527 EUR
Market cap54.83M EUR
Volume220.48K
P/E ratio4.080000
Dividend yield (TTM)0.02%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)0.43901 EUR
Net income (FY)15.87M EUR
Revenue (FY)161.97M EUR
Last report dateMay 11, 2026
About Biote Corp. Class A Common Stock
HeadquartersIRVING
Employees (FY)223.00
Revenue per employee (FY)726.32K EUR
Net income per employee (FY)71.16K EUR
Listed onNasdaq
BTMD conversion tables
 |  |
|---|---|
| 0.5 BTMD | 0.86941 EUR |
| 1 BTMD | 1.738 EUR |
| 5 BTMD | 8.694 EUR |
| 10 BTMD | 17.38 EUR |
| |
|---|---|
| 0.5 EUR | 0.28755 BTMD |
| 1 EUR | 0.5751 BTMD |
| 5 EUR | 2.875 BTMD |
| 10 EUR | 5.751 BTMD |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
BTMD is trading at €1.738, +5.21% over the last 24 hours. Track live moves on the price chart at the top of this page.
The BTMD stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. BTMD is currently trading at €1.738, +5.21% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on BTMD price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. BTMD's P/E ratio is currently 4.080000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from BTMD; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against BTMD's historical range and other companies in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector.
Biote Corp. Class A Common Stock's market cap is currently 54.83M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume220.48K
24h highest1.7388 EUR
24h lowest1.6355 EUR
24h Price movement+5.21%
Start trade with BTMD Perpetual
Sign up to trade